Firm Wire items are announcements made by the firms themselves. The desk confirms that the announcement was published and reproduces its factual content. It does not verify the claims in it, and publication is not an endorsement.
Honigman announced that it had represented Catalio Capital Management as lead investor in Evvy’s $40 million Series B financing. The firm described Catalio as a healthcare-focused investor and Evvy as a women’s health platform serving patients across the United States and working with healthcare providers.
Honigman announced that it had represented 3i, LP in a senior secured financing facility of up to $20 million for Cerenome. The firm said the arrangement used royalty-based repayments and combined initial funding at closing with further advances dependent on specified milestones being achieved.